Cash flow Savara Inc.

Stocks

SVRA

US8051111016

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 14:49:53 14/07/2026 BST			5-day change	1st Jan Change
5.735 ^USD	-0.09%		-8.86%	-6.14%

06-23	Savara Insider Sold Shares Worth $2,241,432, According to a Recent SEC Filing	MT
06-08	Savara Inc. Announces CFO Changes	CI

7e001acfc59d9bada15b1a0b41.WbdMM2RbuOdVNYUusToMt7xkEIKqKuJdhHjt1Ig4t5I.b_98VjET76UmAfZn5Qs4h-kod9b_adoMszSa7LBegOsy0z1BLjbBgxB0zA

Published financial data: SAVARA INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	-	-	-	-	-
Total Revenues	-	-	-	-	-
Cost of Goods Sold, Total	28.99M	27.88M	44.26M	78.03M	81.4M
Gross Profit	-28.99M	-27.88M	-44.26M	-78.03M	-81.4M
Selling General & Admin Expenses, Total	12.35M	10.93M	15.67M	25.04M	42.06M
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	136K	31K	77K	130K	87K
Other Operating Expenses	-844K	-796K	-797K	-797K	-784K
Other Operating Expenses, Total	11.64M	10.16M	14.95M	24.37M	41.36M
Operating Income	-40.63M	-38.04M	-59.21M	-102M	-123M
Interest Expense, Total	-2.28M	-88K	-	-	-
Interest And Investment Income	-	-	4.44M	6.47M	4.16M
Net Interest Expenses	-2.28M	-88K	4.44M	6.47M	4.16M
Currency Exchange Gains (Loss)	-99K	-19K	76K	51K	310K
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-43.01M	-38.15M	-54.7M	-95.88M	-118M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
In Process R&D Expenses	-	-	-	-	-
Other Unusual Items	-	-	-	-	-546K
EBT, Incl. Unusual Items	-43.01M	-38.15M	-54.7M	-95.88M	-119M
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	-43.01M	-38.15M	-54.7M	-95.88M	-119M
Net Income to Company	-43.01M	-38.15M	-54.7M	-95.88M	-119M
Net Income - (IS)	-43.01M	-38.15M	-54.7M	-95.88M	-119M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-43.01M	-38.15M	-54.7M	-95.88M	-119M
Net Income to Common Excl. Extra Items	-43.01M	-38.15M	-54.7M	-95.88M	-119M
Per Share Items
Net EPS - Basic	-0.28	-0.25	-0.33	-0.48	-0.53
Basic EPS - Continuing Operations	-0.28	-0.25	-0.33	-0.48	-0.53
Basic Weighted Average Shares Outstanding	153M	153M	165M	198M	222M
Net EPS - Diluted	-0.28	-0.25	-0.33	-0.48	-0.53
Diluted EPS - Continuing Operations	-0.28	-0.25	-0.33	-0.48	-0.53
Diluted Weighted Average Shares Outstanding	153M	153M	165M	198M	222M
Normalized Basic EPS	-0.18	-0.16	-0.21	-0.3	-0.33
Normalized Diluted EPS	-0.18	-0.16	-0.21	-0.3	-0.33
Supplemental Items
EBITDA	-40.5M	-38.01M	-59.13M	-102M	-123M
EBITA	-40.63M	-38.04M	-59.21M	-102M	-123M
EBIT	-40.63M	-38.04M	-59.21M	-102M	-123M
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	-	-	-	-	-
Deferred Domestic Taxes	-	-	-	-	-
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-26.88M	-23.84M	-34.19M	-59.93M	-73.93M
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	12.35M	10.93M	15.67M	25.04M	42.06M
Research And Development Expense From Footnotes	28.99M	27.88M	44.26M	78.03M	81.4M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., COGS (Total)	1.29M	448K	1.47M	4.45M	4.06M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	1.97M	1.59M	2.71M	5.41M	10.37M
Total Stock-Based Compensation	3.26M	2.04M	4.18M	9.86M	14.42M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	34.01M	52.1M	26.58M	15.13M	33.18M
Short Term Investments	128M	73.85M	136M	182M	203M
Total Cash And Short Term Investments	162M	126M	163M	197M	237M
Accounts Receivable, Total	-	-	-	-	-
Other Receivables	1.14M	954K	1M	1.04M	1.25M
Total Receivables	1.14M	954K	1M	1.04M	1.25M
Prepaid Expenses	427K	231K	176K	131K	215K
Other Current Assets, Total	1.9M	1.82M	2.17M	4.18M	3.55M
Total Current Assets	165M	129M	166M	202M	242M
Gross Property Plant And Equipment	2.4M	2.09M	2.67M	2.53M	2.43M
Accumulated Depreciation	-2.08M	-1.92M	-2.01M	-2.16M	-2.33M
Net Property Plant And Equipment	324K	167K	657K	365K	100K
Goodwill	-	-	-	-	-
Other Intangibles, Total	11.27M	10.66M	10.96M	10.34M	11.64M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	-	-	-	42K	84K
Total Assets	177M	140M	178M	213M	253M
Liabilities
Accounts Payable, Total	1.44M	1.33M	3.5M	4.54M	5.76M
Accrued Expenses, Total	4.75M	4.47M	6.95M	10.04M	14.27M
Current Portion of Long-Term Debt	8.33M	-	-	-	-
Current Portion of Leases	135K	64K	143K	143K	7K
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	-	-	-	-	362K
Total Current Liabilities	14.66M	5.87M	10.6M	14.72M	20.4M
Long-Term Debt	17.32M	26.08M	26.35M	26.62M	29.91M
Long-Term Leases	96K	46K	201K	87K	-
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	21K	8K	46K	-	-
Total Liabilities	32.1M	32M	37.19M	41.43M	50.3M
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	116K	116K	140K	173K	204K
Additional Paid In Capital	445M	447M	534M	661M	811M
Retained Earnings	-301M	-339M	-393M	-489M	-608M
Comprehensive Income and Other	5K	-605K	-271K	-750K	-87K
Total Common Equity	144M	108M	140M	171M	203M
Total Equity	144M	108M	140M	171M	203M
Total Liabilities And Equity	177M	140M	178M	213M	253M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	153M	153M	183M	216M	253M
ECS Total Common Shares Outstanding	153M	153M	183M	216M	253M
Book Value / Share	0.95	0.71	0.77	0.79	0.8
Tangible Book Value	133M	97.12M	129M	161M	191M
Tangible Book Value Per Share	0.87	0.64	0.71	0.75	0.76
Total Debt	25.89M	26.19M	26.69M	26.85M	29.91M
Net Debt	-136M	-99.76M	-136M	-170M	-207M
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	2M	1.83M	1.95M	1.99M	2.1M
Full Time Employees	22	28	37	59	70
Part Time Employees	-	-	-	-	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-43.01M	-38.15M	-54.7M	-95.88M	-119M
Depreciation & Amortization - CF	367K	167K	175K	275K	245K
Depreciation & Amortization, Total	367K	167K	175K	275K	245K
Amortization of Deferred Charges, Total - (CF)	552K	334K	271K	271K	453K
(Gain) Loss on Sale of Investments - (CF)	1.6M	75K	-4.98M	-5.44M	-2.87M
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	3.26M	2.04M	4.18M	9.86M	14.42M
Other Operating Activities, Total	-4K	19K	-76K	-	546K
Change In Accounts Receivable	-	-	-	-	-
Change In Accounts Payable	-1.76M	-319K	4.54M	4.2M	4.81M
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-1.08M	1.28M	-468K	-2.37M	195K
Cash from Operations	-40.08M	-34.55M	-51.06M	-89.09M	-101M
Capital Expenditure	-57K	-9K	-296K	-25K	-22K
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-69.4M	52.65M	-56.82M	-39.92M	-18.42M
Cash from Investing	-69.46M	52.64M	-57.12M	-39.94M	-18.44M
Long-Term Debt Issued, Total	-	26.44M	-	-	29.6M
Total Debt Issued	-	26.44M	-	-	29.6M
Long-Term Debt Repaid, Total	-	-26.35M	-	-	-27.23M
Total Debt Repaid	-	-26.35M	-	-	-27.23M
Issuance of Common Stock	85.91M	2K	72.11M	125M	141M
Repurchase of Common Stock	-78K	-3K	-1.21M	-995K	-5.14M
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	34.98M	-	11.87M	-6.16M	-
Cash from Financing	121M	87K	82.78M	118M	138M
Foreign Exchange Rate Adjustments	-137K	-90K	-118K	-5K	-277K
Net Change in Cash	11.13M	18.09M	-25.52M	-11.46M	18.05M
Supplemental Items
Cash Interest Paid	1.97M	1.61M	2.04M	2.12M	3.2M
Levered Free Cash Flow	-25.24M	-21.22M	-28.37M	-51.5M	-55.52M
Unlevered Free Cash Flow	-24.36M	-21.5M	-28.64M	-51.77M	-55.97M
Change In Net Working Capital	2.54M	-77K	-4.31M	-2.12M	-6.11M
Net Debt Issued / Repaid	-	88K	-	-	2.37M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-18.51	-15.03	-23.32	-32.78	-32.91
Return on Total Capital	-19.53	-15.63	-24.59	-35.05	-35.58
Return On Equity %	-41.19	-30.24	-44.08	-61.5	-63.45
Return on Common Equity	-41.19	-30.24	-44.08	-61.5	-63.45
Margin Analysis
Gross Profit Margin %	-	-	-	-	-
SG&A Margin	-	-	-	-	-
EBITDA Margin %	-	-	-	-	-
EBITA Margin %	-	-	-	-	-
EBIT Margin %	-	-	-	-	-
Income From Continuing Operations Margin %	-	-	-	-	-
Net Income Margin %	-	-	-	-	-
Net Avail. For Common Margin %	-	-	-	-	-
Normalized Net Income Margin	-	-	-	-	-
Levered Free Cash Flow Margin	-	-	-	-	-
Unlevered Free Cash Flow Margin	-	-	-	-	-
Asset Turnover
Asset Turnover	-	-	-	-	-
Fixed Assets Turnover	-	-	-	-	-
Short Term Liquidity
Current Ratio	11.26	21.98	15.66	13.73	11.85
Quick Ratio	11.1	21.63	15.44	13.44	11.66
Operating Cash Flow to Current Liabilities	-2.73	-5.89	-4.82	-6.05	-4.95
Average Days Payable Outstanding	25.42	18.18	19.95	18.88	23.1
Long Term Solvency
Total Debt/Equity	17.92	24.3	19.02	15.66	14.73
Total Debt / Total Capital	15.19	19.55	15.98	13.54	12.84
LT Debt/Equity	12.05	24.24	18.91	15.58	14.72
Long-Term Debt / Total Capital	10.22	19.5	15.89	13.47	12.83
Total Liabilities / Total Assets	18.18	22.89	20.95	19.46	19.85
EBIT / Interest Expense	-17.81	-432.31	-	-	-
EBITDA / Interest Expense	-17.75	-431.95	-	-	-
(EBITDA - Capex) / Interest Expense	-17.77	-432.06	-	-	-
Total Debt / EBITDA	-0.64	-0.69	-0.45	-0.26	-0.24
Net Debt / EBITDA	3.35	2.62	2.3	1.66	1.68
Total Debt / (EBITDA - Capex)	-0.64	-0.69	-0.45	-0.26	-0.24
Net Debt / (EBITDA - Capex)	3.34	2.62	2.29	1.66	1.68
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-	-
Gross Profit, 1 Yr. Growth %	-16.65	-3.84	58.76	76.29	4.33
EBITDA, 1 Yr. Growth %	-11.68	-6.14	55.56	72.95	19.95
EBITA, 1 Yr. Growth %	-11.87	-6.37	55.64	72.94	19.89
EBIT, 1 Yr. Growth %	-11.87	-6.37	55.64	72.94	19.89
Earnings From Cont. Operations, 1 Yr. Growth %	-13.3	-11.31	43.38	75.29	23.94
Net Income, 1 Yr. Growth %	-13.3	-11.31	43.38	75.29	23.94
Normalized Net Income, 1 Yr. Growth %	-9.09	-11.31	43.38	75.29	23.37
Diluted EPS Before Extra, 1 Yr. Growth %	-65.55	-11.31	32.59	46.12	10.46
Net Property, Plant and Equip., 1 Yr. Growth %	107.69	-48.46	1.19K	35.19	-39.39
Total Assets, 1 Yr. Growth %	80.67	-20.85	27.03	19.89	19.05
Tangible Book Value, 1 Yr. Growth %	155.39	-27.1	33.25	24.5	18.86
Common Equity, 1 Yr. Growth %	124.44	-25.41	30.24	22.14	18.48
Cash From Operations, 1 Yr. Growth %	0.62	-13.79	47.77	74.47	13.41
Capital Expenditures, 1 Yr. Growth %	21.28	-84.21	3.19K	-91.55	-12
Levered Free Cash Flow, 1 Yr. Growth %	-9.41	-15.91	33.67	81.53	7.87
Unlevered Free Cash Flow, 1 Yr. Growth %	-11.21	-11.75	33.2	80.76	8.18
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-	-
Gross Profit, 2 Yr. CAGR %	-13.54	-10.47	23.56	67.3	35.61
EBITDA, 2 Yr. CAGR %	-10.39	-8.95	20.84	64.03	44.03
EBITA, 2 Yr. CAGR %	-10.51	-9.16	20.71	64.06	43.99
EBIT, 2 Yr. CAGR %	-10.51	-9.16	20.71	64.06	43.99
Earnings From Cont. Operations, 2 Yr. CAGR %	-25.82	-12.31	12.77	58.53	47.4
Net Income, 2 Yr. CAGR %	-25.82	-12.31	12.77	58.53	47.4
Normalized Net Income, 2 Yr. CAGR %	-8.25	-10.21	12.77	58.53	47.06
Diluted EPS Before Extra, 2 Yr. CAGR %	-54.55	-44.72	8.44	39.19	27.04
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.06	3.47	42.4	167.52	-39.14
Total Assets, 2 Yr. CAGR %	13.87	19.58	0.27	23.41	19.47
Tangible Book Value, 2 Yr. CAGR %	21.27	36.45	-1.44	28.8	21.64
Common Equity, 2 Yr. CAGR %	19.2	29.38	-1.44	26.13	20.3
Cash From Operations, 2 Yr. CAGR %	-5.75	-6.87	12.87	60.57	40.67
Capital Expenditures, 2 Yr. CAGR %	-37.94	-56.24	127.88	66.67	-72.74
Levered Free Cash Flow, 2 Yr. CAGR %	1.92	-12.72	6.02	55.77	39.89
Unlevered Free Cash Flow, 2 Yr. CAGR %	-0.95	-11.48	8.42	55.17	39.8
Compound Annual Growth Rate Over Three Years
Gross Profit, 3 Yr. CAGR %	-	-10.42	8.37	39.1	42.93
EBITDA, 3 Yr. CAGR %	-4.23	-8.99	8.85	36.18	47.78
EBITA, 3 Yr. CAGR %	-4.49	-9.15	8.69	36.08	47.77
EBIT, 3 Yr. CAGR %	-4.49	-9.15	8.69	36.08	47.77
Earnings From Cont. Operations, 3 Yr. CAGR %	-11.24	-21.27	3.3	30.63	46.04
Net Income, 3 Yr. CAGR %	-11.24	-21.27	3.3	30.63	46.04
Normalized Net Income, 3 Yr. CAGR %	-2.64	-9.28	4.95	30.63	45.82
Diluted EPS Before Extra, 3 Yr. CAGR %	-46.58	-43.21	-26.01	19.77	28.86
Net Property, Plant and Equip., 3 Yr. CAGR %	-14.7	-22.01	61.49	4.05	25.16
Total Assets, 3 Yr. CAGR %	5.06	0.87	22.02	6.43	21.94
Tangible Book Value, 3 Yr. CAGR %	17.9	2.35	35.37	6.54	25.4
Common Equity, 3 Yr. CAGR %	10.12	1.95	29.67	5.87	23.52
Cash From Operations, 3 Yr. CAGR %	0.68	-8.51	8.63	30.5	43
Capital Expenditures, 3 Yr. CAGR %	-26.06	-60.68	84.67	-24.02	34.71
Levered Free Cash Flow, 3 Yr. CAGR %	4.46	-4.41	0.61	26.84	37.79
Unlevered Free Cash Flow, 3 Yr. CAGR %	2.52	-4.69	1.44	28.56	37.56
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	-
Gross Profit, 5 Yr. CAGR %	135.53	-	-	15.01	18.54
EBITDA, 5 Yr. CAGR %	30.74	8.61	5.1	15.19	21.75
EBITA, 5 Yr. CAGR %	29.99	8.32	4.89	15.08	21.64
EBIT, 5 Yr. CAGR %	29.99	8.32	4.89	15.08	21.64
Earnings From Cont. Operations, 5 Yr. CAGR %	31.54	5.07	-2.32	4.17	19.09
Net Income, 5 Yr. CAGR %	31.54	5.07	-2.32	4.17	19.09
Normalized Net Income, 5 Yr. CAGR %	30.7	7.02	3.25	13.41	20.11
Diluted EPS Before Extra, 5 Yr. CAGR %	-45.05	-32.31	-29.09	-18.71	-8.15
Net Property, Plant and Equip., 5 Yr. CAGR %	-16.39	-28.99	4.71	0.73	-8.51
Total Assets, 5 Yr. CAGR %	43.59	-2.62	3.12	9.34	20.99
Tangible Book Value, 5 Yr. CAGR %	27.9	1.04	9.74	12.2	29.7
Common Equity, 5 Yr. CAGR %	32.13	-2.01	5.34	11.01	25.84
Cash From Operations, 5 Yr. CAGR %	36.79	4.12	5.39	14.57	20.46
Capital Expenditures, 5 Yr. CAGR %	48.1	-55.13	15.99	-29.93	-14.09
Levered Free Cash Flow, 5 Yr. CAGR %	37.21	6.73	5.08	16.21	14.79
Unlevered Free Cash Flow, 5 Yr. CAGR %	36.31	7.46	4.84	15.83	15.32